Literature summary extracted from
Koukoulitsa, C.; Bailly, F.; Pegklidou, K.; Demopoulos, V.J.; Cotelle, P.
Evaluation of aldose reductase inhibition and docking studies of 6-nitro and 6,6-dinitrorosmarinic acids (2010), Eur. J. Med. Chem., 45, 1663-1666.
Application
EC Number |
Application |
Comment |
Organism |
---|
1.1.1.21 |
medicine |
aldose reductase ALR2 is a target enzyme for the treatment of diabetic complications |
Homo sapiens |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
1.1.1.21 |
6',6''-dinitrorosmarinic acid |
docking structure with ALR2, overview |
Homo sapiens |
|
1.1.1.21 |
6'-nitrorosmarinic acid |
docking structure with ALR2, overview |
Homo sapiens |
|
1.1.1.21 |
rosmarinic acid |
docking structure with ALR2, overview |
Homo sapiens |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
1.1.1.21 |
Homo sapiens |
P15121 |
ALR2 |
- |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
1.1.1.21 |
aldose reductase |
- |
Homo sapiens |
1.1.1.21 |
ALR2 |
- |
Homo sapiens |
General Information
EC Number |
General Information |
Comment |
Organism |
---|
1.1.1.21 |
metabolism |
aldose reductase ALR2 acts in the polyol metabolic pathway |
Homo sapiens |